Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-SP IKT HOLDINGS LLC(8.69%),SP Soleus Holdings LLC(8.69%)
Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Soleus Private Equity Fund III, L.P.(9.99%),Soleus Private Equity GP III, LLC(9.99%), etc.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.